TCTR20170513004已完成2 期
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY OF DIFFERENT DOSES OF ORAL CHANNA STRIATUS EXTRACT AMONG PRIMARY KNEE OSTEOARTHRITIS PATIENTS
niversiti Sains Malaysia0 个研究点目标入组 120 人开始时间: 2017年5月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 Years 至 90 Years（—）
- 性别
- All
入选标准
- •1.Patients with unilateral or bilateral knee osteoarthritis according to clinical and radiological criteria of the American College of Rheumatology (ACR).
- •2.Have a radiological grade between I and III, as measured with the Kellgren-Lawrence method of Classification.
排除标准
- •1-Patient with secondary knee osteoarthritis, such as post traumatic OA, inflammatory arthritis, specifically rheumatoid arthritis, active gout
- •2-Disabling co-morbid condition such as renal disease, liver disease, neoplasm, and other rheumatic diseases.
- •3-Pregnancy or nursing.
- •4-Patient with severe knee pain and willing for surgical intervention.
- •5-Those who had joint lavage, arthroscopy, or treatment with hyaluronic acid, or glucosamine during the previous 6 months.
- •6-Patient who had been treated with intra-articular corticosteroids during the past 3 months.
- •7-Patient who have allergic to oral C.striatus
研究者
相似试验
已完成
不适用
A DOUBLE-BLIND, RANDOMLY CONTROLLED PLACEBO STUDY TO EVALUATE THE RENAL PROTECTIVE EFFECTS OF LOSARTAN IN PATIENTS WITH DIABETES MELLITUS NON-INSULIN DEPENDENTS AND NEPHROPATHY-E119 Non-insulin-dependent diabetes mellitus, without complicationsNon-insulin-dependent diabetes mellitus, without complicationsE119PER-077-00MERCK SHARP & DOHME PERU S.R.L.,
进行中（未招募）
1 期
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF A FOUR-WEEK TREATMENT WITH YM758 IN SUBJECTS WITH STABLE ANGINA. - IRISStable angina pectorisEUCTR2005-002456-18-SKAstellas Pharma Europe B.V.210
进行中（未招募）
1 期
A study to assess the efficacy and safety of three doses of orvepitant in subjects with chronic refractory coughChronic Refractory CoughMedDRA version: 20.0Level: LLTClassification code 10066656Term: Chronic coughSystem Organ Class: 100000004855EUCTR2016-004979-49-GBeRRe Therapeutics Ltd.292
进行中（未招募）
不适用
A STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S)COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITHETANERCEPT PLUS DMARD(S)Rheumatoid ArthritisEUCTR2011-005448-87-HUPfizer Inc, 235 East 42nd Street, New York, NY 10017320
进行中（未招募）
不适用
A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S)COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITHETANERCEPT PLUS DMARD(S)MedDRA version: 16.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2011-005448-87-CZPfizer Inc, 235 East 42nd Street, New York, NY 10017320